Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

May 15, 2020; Volume 17,Issue 2

Review

  • You have access
    ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance
    Wanjiru Muriithi, Lucy Wanjiku Macharia, Carlos Pilotto Heming, Juliana Lima Echevarria, Atunga Nyachieo, Paulo Niemeyer Filho and Vivaldo Moura Neto
    Cancer Biology & Medicine May 2020, 17 (2) 253-269; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0284
  • You have access
    Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression
    Xiaofan Wei and Hongquan Zhang
    Cancer Biology & Medicine May 2020, 17 (2) 270-281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0420
  • You have access
    Role of the mechanical microenvironment in cancer development and progression
    Qiuping Liu, Qing Luo, Yang Ju and Guanbin Song
    Cancer Biology & Medicine May 2020, 17 (2) 282-292; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0437
  • You have access
    Triple negative breast cancer: special histological types and emerging therapeutic methods
    Lu Cao and Yun Niu
    Cancer Biology & Medicine May 2020, 17 (2) 293-306; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0465
  • You have access
    Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer
    Yanan Li, Jingqi Xin, Yongbing Sun, Tao Han, Hui Zhang and Feifei An
    Cancer Biology & Medicine May 2020, 17 (2) 307-327; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0072

Original Article

  • You have access
    CDK11 negatively regulates Wnt/β-catenin signaling in the endosomal compartment by affecting microtubule stability
    Danmin Ou, Lin Chen, Jiang He, Zhuoxian Rong, Jie Gao, Zhi Li, Liyu Liu, Feiyu Tang, Jiang Li, Yuezhen Deng and Lunquan Sun
    Cancer Biology & Medicine May 2020, 17 (2) 328-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0229
  • You have access
    Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling via PHLPP1 in colorectal cancer
    Yijye Chern, Peter Zhang, Hyelim Ju and Isabella T. Tai
    Cancer Biology & Medicine May 2020, 17 (2) 343-356; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0261
  • You have access
    CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma
    Ting Li, Si Wu, Lei Jia, Wenfeng Cao, Yuan Yao, Gang Zhao and Hui Li
    Cancer Biology & Medicine May 2020, 17 (2) 357-370; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0107
  • You have access
    KIF18B promotes tumor progression in osteosarcoma by activating β-catenin
    Tian Gao, Ling Yu, Zhiwei Fang, Jiayong Liu, Chujie Bai, Shu Li, Ruifeng Xue, Lu Zhang, Zhichao Tan and Zhengfu Fan
    Cancer Biology & Medicine May 2020, 17 (2) 371-386; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0452
  • You have access
    DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
    Yangling Li, Dongmei Zhou, Shuang Xu, Mingjun Rao, Zuoyan Zhang, Linwen Wu, Chong Zhang and Nengming Lin
    Cancer Biology & Medicine May 2020, 17 (2) 387-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0380
  • You have access
    Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development
    Qi Wang, Qin Tang, Lijun Zhao, Qiong Zhang, Yuxin Wu, Hui Hu, Lanlan Liu, Xiang Liu, Yanhong Zhu, Anyuan Guo and Xiangliang Yang
    Cancer Biology & Medicine May 2020, 17 (2) 401-417; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0335
  • You have access
    Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling
    Xiaoling Zhang, Yan Zhang, Yanan Jia, Tingting Qin, Cuicui Zhang, Yueya Li, Chengmou Huang, Zhujun Liu, Jing Wang and Kai Li
    Cancer Biology & Medicine May 2020, 17 (2) 418-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0215
  • You have access
    Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab
    Chao Yang, Yanli Tan, Hongzhao Qi, Junhu Zhou, Lixia Long, Qi Zhan, Yunfei Wang, Xubo Yuan and Chunsheng Kang
    Cancer Biology & Medicine May 2020, 17 (2) 433-443; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0292
  • You have access
    Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer
    Juan Moreno-Rubio, Santiago Ponce, Rosa Álvarez, María Eugenia Olmedo, Sandra Falagan, Xabier Mielgo, Fátima Navarro, Patricia Cruz, Luis Cabezón-Gutiérrez, Carlos Aguado, Gonzalo Colmenarejo, Marta Muñoz-Fernández de Leglaria, Ana Belén Enguita, María Cebollero, Amparo Benito, Isabel Alemany, Carolina del Castillo, Ricardo Ramos, Ana Ramírez de Molina, Enrique Casado and Maria Sereno
    Cancer Biology & Medicine May 2020, 17 (2) 444-457; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0363
  • You have access
    Identification of novel Lynch syndrome mutations in Chinese patients with endometriod endometrial cancer
    Caixia Ren, Yan Liu, Yuxiang Wang, Yan Tang, Yawei Wei, Congrong Liu and Hongquan Zhang
    Cancer Biology & Medicine May 2020, 17 (2) 458-467; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0295
  • You have access
    Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors
    Lei Zhu, Xiaofeng Li, Jian Wang, Qiang Fu, Jianjing Liu, Wenchao Ma, Wengui Xu and Wei Chen
    Cancer Biology & Medicine May 2020, 17 (2) 468-477; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0428
  • You have access
    Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis
    Hongcai Yang, Yi Yang, Jianping Dou, Rui Cui, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Xiaoling Yu, Xiang Zhou, Jie Yu and Ping Liang
    Cancer Biology & Medicine May 2020, 17 (2) 478-491; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0246
  • You have access
    Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications
    Xiaofei Zhu, Di Chen, Yangsen Cao, Xianzhi Zhao, Xiaoping Ju, Yuxin Shen, Fei Cao, Shuiwang Qing, Fang Fang, Zhen Jia and Huojun Zhang
    Cancer Biology & Medicine May 2020, 17 (2) 492-500; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0101
  • You have access
    Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy
    Zhichao Liao, Ting Li, Chao Zhang, Xinyue Liu, Ruwei Xing, Sheng Teng, Yun Yang, Gang Zhao, Xu Bai, Jun Zhao and Jilong Yang
    Cancer Biology & Medicine May 2020, 17 (2) 501-512; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0397

Erratum

  • You have access
    Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients
    Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu and Chengping Hu
    Cancer Biology & Medicine May 2020, 17 (2) 513; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0029
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 17 (2)
Cancer Biology & Medicine
Vol. 17, Issue 2
15 May 2020
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Review
  • Original Article
  • Erratum

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire